We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+15.03%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$6.7B
AUM Growth
-$175M
Cap. Flow
-$285M
Cap. Flow %
-4.26%
Top 10 Hldgs %
24.91%
Holding
2,523
New
688
Increased
486
Reduced
584
Closed
615

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$16.5M
2
MSI icon
Motorola Solutions
MSI
+$15.5M
3
RKT icon
Rocket Companies
RKT
+$15.4M
4
V icon
Visa
V
+$14.6M
5
WH icon
Wyndham Hotels & Resorts
WH
+$14.4M

Top Sells

Rank Stock Value
1
CLM icon
Cornerstone Strategic Value Fund
CLM
+$42.4M
2
LITE icon
Lumentum
LITE
+$25.8M
3
HD icon
Home Depot
HD
+$23.8M
4
WMT icon
Walmart Inc
WMT
+$22.8M
5
CIEN icon
Ciena
CIEN
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 10.49%
2 Healthcare 9.98%
3 Consumer Discretionary 7.16%
4 Industrials 6.43%
5 Financials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL.B icon
2376
U-Haul Holding Co Series N
UHAL.B
$12.6B
-43,358
Closed -$2.21M
ULCC icon
2377
CALL
Frontier Group Holdings
ULCC
$1.84B
-78,400
Closed -$346K
UMH
2378
UMH Properties
UMH
$1.3B
-27,726
Closed -$412K
UNH icon
2379
CALL
UnitedHealth
UNH
$370B
-1,200
Closed -$414K
UNM icon
2380
Unum
UNM
$14.5B
-2,954
Closed -$230K
URNM icon
2381
Sprott Uranium Miners ETF
URNM
$1.89B
-6,803
Closed -$411K
URTH icon
2382
CALL
iShares MSCI World ETF
URTH
$8.22B
-30,000
Closed -$2.4M
USPH icon
2383
US Physical Therapy
USPH
$1.15B
-2,443
Closed -$208K
UTF icon
2384
Cohen & Steers Infrastructure Fund
UTF
$3.08B
-379,643
Closed -$9.42M
UTHR icon
2385
CALL
United Therapeutics
UTHR
$22B
-800
Closed -$335K
UTHR icon
2386
United Therapeutics
UTHR
$22B
-3,000
Closed -$1.26M
UTHR icon
2387
PUT
United Therapeutics
UTHR
$22B
-86,900
Closed -$36.4M
UWMC icon
2388
CALL
UWM Holdings
UWMC
$661M
-423,700
Closed -$2.58M
VAL icon
2389
Valaris
VAL
$5.41B
-31,601
Closed -$1.54M
VKTX icon
2390
Viking Therapeutics
VKTX
$3.84B
-11,205
Closed -$294K
EMPD
2391
Empery Digital
EMPD
$83.2M
-581,101
Closed -$4.37M
VLTO icon
2392
Veralto
VLTO
$23.5B
-3,955
Closed -$422K
VMEO
2393
DELISTED
Vimeo
VMEO
-21,606
Closed -$167K
VNDA icon
2394
Vanda Pharmaceuticals
VNDA
$321M
-14,446
Closed -$72.1K
VNT icon
2395
Vontier
VNT
$4.76B
-5,029
Closed -$211K
VRDN icon
2396
Viridian Therapeutics
VRDN
$2.3B
-83,594
Closed -$1.8M
VRNA
2397
CALL
DELISTED
Verona Pharma
VRNA
-25,000
Closed -$2.67M
VRNA
2398
DELISTED
Verona Pharma
VRNA
-20,150
Closed -$2.15M
VRNT
2399
DELISTED
Verint Systems
VRNT
-68,031
Closed -$1.38M
VRTX icon
2400
Vertex Pharmaceuticals
VRTX
$121B
-611
Closed -$239K

Similar funds

Boothbay Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, Boothbay Fund Management held 2,523 positions worth $6.7B, down 2.5% from $6.88B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boothbay Fund Management withdrew a net $285M in Q4 2025, closing 615 positions and reducing 584 holdings. Its most notable exit was Mr. Cooper, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Visa worth $15M.

  • Boothbay Fund Management's largest Q4 2025 buy was Visa: 42,763 shares worth $15M.
  • Boothbay Fund Management added most to Vaxcyte in Q4 2025, an estimated $16.5M increase.
  • Boothbay Fund Management's biggest Q4 2025 reduction was Cornerstone Strategic Value Fund, cutting an estimated $42.4M.
  • Boothbay Fund Management fully exited Mr. Cooper in Q4 2025, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 25% of its $6.7B portfolio in Q4 2025.
  • Boothbay Fund Management opened 688 new positions and closed 615 in Q4 2025.
  • Boothbay Fund Management's portfolio value fell 2.5% quarter-over-quarter to $6.7B.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.